Periodic Reporting for period 1 - EicoMet (Targeting eicosanoid metabolism to overcome tumor immunosuppression)

Although the field of cancer immunotherapy has seen exciting therapeutic advances over the past decade, a large number of patients with solid tumors display resistance. Melanoma is the most aggressive form of skin cancer and the first approved tumor indication for immune...